Physician profile
Sameh S Naguib
NPI 1568415685
$817.70
in general payments reported to CMS, 2019-2025
15 companies · $93.14 in 2025
The $93.14 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $44.63 · 2022: $119 · 2023: $143 · 2024: $191 · 2025: $93.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $188.69 | 2019-2024 | |
| Abbvie INC. | $141.35 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $75.72 | 2019-2023 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.67 | 2019-2024 | Lifevest |
| Mallinckrodt Hospital Products INC. | $61.82 | 2022-2024 | Terlivaz |
| Vifor Pharma, INC. | $54.08 | 2019-2020 | |
| Dexcom, INC. | $43.82 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $33.70 | 2023 | Dificid |
| Astellas Pharma US INC | $28.56 | 2024 | Vyloy |
| Allergan, INC. | $22.34 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.22 | 2019 | |
| Portola Pharmaceuticals, LLC | $21.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.27 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.21 | 2025 | |
| Melinta Therapeutics, LLC | $15.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Naguib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.